Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 60 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 9676788

    Aza-epoxy-guaiane derivatives and treatment of cancer

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  2. US 9675678

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  3. US 9675655

    Compositions for the treatment of dermatological conditions, disorders or diseases

    Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  4. US 9675623

    Non-surgical method of treatment for cataract

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted

  5. US 9670141

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  6. US 9669004

    Daidzein analogs as treatment for cancer

    United States Department of Agriculture · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  7. US 9662306

    Compositions and methods for diagnosis and treatment of metabolic syndrome

    United States of America as represented by the Secretary of the Air Force · Granted May 30, 2017 · Expires May 25, 2037

    granted

  8. US 9663504

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted May 30, 2017 · Expires May 25, 2037

    granted

  9. US 9663569

    Use of blocking agents of bone morphogenic protein (BMP) signalling for the treatment of neuroinflammatory and neurodegenerative diseases

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted May 30, 2017 · Expires May 25, 2037

    granted

  10. US 9663521

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 30, 2017 · Expires May 25, 2037

    granted

  11. US 9662377

    Therapeutic composition for treatment of glioblastoma

    Regents of the University of Minnesota · Granted May 30, 2017 · Expires May 25, 2037

    granted

  12. US 9662322

    Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 30, 2017 · Expires May 25, 2037

    granted

  13. US 9649291

    Treatment for obesity

    Jazz Pharmaceuticals International III Limited · Granted May 16, 2017 · Expires May 11, 2037

    granted

  14. US 9649327

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  15. US 9650352

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 16, 2017 · Expires May 11, 2037

    granted

  16. US 9650417

    Treatments for gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  17. US 9650607

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted May 16, 2017 · Expires May 11, 2037

    granted

  18. US 9650648

    Methods and compositions for treatment of a genetic condition

    Sangamo Biosciences, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  19. US 9649320

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted

  20. US 9649358

    Methods for use of neural stem cell compositions for treatment of central nervous system lesions

    The Regents of the University of California · Granted May 16, 2017 · Expires May 11, 2037

    granted

  21. US 9642898

    Use of serine protease inhibitors in the treatment of neutropenia

    MED DISCOVERY S.A. · Granted May 9, 2017 · Expires May 4, 2037

    granted

  22. US 9644216

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 9, 2017 · Expires May 4, 2037

    granted

  23. US 2017119760

    USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

    AB SCIENCE [FR] · Granted May 4, 2017 · Expires Apr 29, 2037

    granted

  24. US 9624306

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.